In Vitro Diagnostics Market - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 20162025 © Coherent market Insights. All Rights Reserved In Vitro Diagnostics (IVD) Market Overview : The Global In Vitro Diagnostics (IVD) Market was valued at US$ 19,635.8 million in 2015 and is projected to expand at a CAGR of 4.3% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing number of applications in chronic cancer and other chronic diseases is projected to support growth of the In vitro diagnostics (IVD) market over the forecast period. In vitro diagnostics (IVDs) are currently an important part of the healthcare sector. IVD devices and services are used in diagnosing, monitoring, and screening in various chronic and acute disorders. This further contributes to the availability of medical information related to the patient. Due to specificity of treatments, IVDs is expected to minimize the stay of the patients in hospitals and convalescences, which results in healthier population and cost effective treatment that favors economic growth in the long run. IVD plays an important role in the global healthcare industry as it is the initial point of any treatment for getting information regarding the ailments. The IVD market is projected to witness rapid growth fueled by advancements in various diagnosing and medical devices technologies with developed tools in diagnostics, early detection of the disease along with rise in availability of over-the-counter tests. Due to the application of IVDs in medical care it adds a significant value in the planned treatment processes enhancing better health results. Furthermore, in vitro diagnostics are the sequences of tests that are able to detect diseases symptoms through which physician can conclude the type of treatment to be given to the patient in very short period of time depending upon the quality of medical. There are various government guidelines to regulate the type of in vitro diagnostic tests. According to the FDA, the in vitro diagnostic devices are regulated through the Medical Device Amendments of 1976, which further divides the in vitro diagnostic products into three class such as class I, II and III that includes the products depending upon the level of regulatory control that can assure the safety and effectiveness. © Coherent market Insights. All Rights Reserved Clinical chemistry product type segment in the in vitro diagnostic products market was the largest segment with significant contribution as compared to all the segments. There are various factors that affects the growth of the products in in vitro diagnostic market such as high unmet healthcare needs in categories of infectious disease, chronic disease and other acute allergies furthermore, increase in prevalence of cancer along with growth in demand for lab automation is expected to support the in vitro diagnostic market significantly in the near future. In 2015, according to the National Cancer Institute, majority of share in the type of cancer was contributed by lung and bronchus cancer, followed by colon, rectum and other type of cancers. Furthermore, in 2015, around 1.7 million new cases of cancer were expected to be diagnosed in the U.S., which further marked the source for rise in diagnostic tests globally. Companies involved in the in vitro diagnostics devices manufacturing are highly active in expanding their product portfolio on the back drop of rise in number of applications of the IVD in healthcare sector. This is expected to provide wide choices to the physicians to choose for the appropriate type of test in particular symptoms, which is further expected to favor the growth of IVD market growth in the near future. Furthermore, acquisitions in the IVD market are frequent as compared to other sectors. Factor that encourage this trend include companies focusing on introducing new technologies, entry into new business segment and geographical expansion. The IVD market is undergoing a trend of strategic mergers and acquisitions, with market players focusing on enhancing their market presence. In 2015, Roche acquired Signature Diagnostics AG – based in Potsdam, Germany – this is expected further to strengthen the company’s next generation sequencing (NGS) diagnostic segment. To know the latest trends and insights prevalent in the In vitro diagnostics (IVD) market, click the link below: https://www.coherentmarketinsights.com/market-insight/in-vitro-diagnostics-ivd-market-195 © Coherent market Insights. All Rights Reserved Key takeaways of the market: The global In vitro diagnostics (IVD) market is expected to expand at a CAGR of 4.3% during the forecast period (2016– 2024). Rising prevalence of chronic diseases across the globe is expected to favor the market for In vitro diagnostics over the forecast period. The clinical chemistry product type segment in the global In vitro diagnostics (IVD) market was estimated to be the largest in 2015 and is expected to dominate throughout the forecast period in terms of value. Increasing prevalence for infectious disease due to poor infrastructure in emerging economies is expected to favor the growth of In vitro diagnostics (IVD) market in the near future. In terms of product type, the molecular diagnostics product type segment is expected to expand at a significant CAGR of 8.2% during the forecast period, owing to rise in rise in number of research institutes and demand for novel drugs in the market The global In vitro diagnostics (IVD) market is characterized by strategic research and development and advancements in the technology of in vitro diagnostic services including the rise in various applications over the forecast period. Some of the major players are Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux, Becton, Dickinson and Company and Danaher Corporation Get an exclusive discount on this report: https://www.coherentmarketinsights.com/insight/request-discount/195 © Coherent market Insights. All Rights Reserved ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES ABOUT COHERENT MARKET INSIGHTS Industries we cater SECTOR COVERAGE Healthcare BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL Chemicals & Materials Bulk Chemicals Advanced Materials Speciality and Fine Chemicals Green Chemicals Food Ingredients © Coherent market Insights. All Rights Reserved Cosmetic Ingredients Polymers & Resins ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS 100+ Insights Published Per Year 150+ Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS SURVEY RESEAR CH EXCEL FORECAST DATABASE CUSTOMIZED SOLUTIONS COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702 © Coherent market Insights. All Rights Reserved

In Vitro Diagnostic (IVD) market share has witnessed increase in recent past, further highlighted its key role in the healthcare industry.